New Key Statistics Module, Z-Score and F-Score
XSAT:VAXXA Key Ratios
| Market Cap kr M | 21.11 |
| Enterprise Value kr M | 16.03 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.82 |
| Price/Sales | 0.23 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 67.00 |
| EPS (TTM) kr | -0.95 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 51.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.01 |
| EV-to-EBITDA | -25.22 |
| PEG | -- |
| Shares Outstanding M | 25.29 |
| Net Margin (%) | -4.06 |
| Operating Margin % | -3.22 |
| Pre-tax Margin (%) | -4.06 |
| Quick Ratio | 1.39 |
| Current Ratio | 1.39 |
| ROA % (ttm) | -16.41 |
| ROE % (ttm) | -41.44 |
| ROIC % (ttm) | -13.39 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.18 |
XSAT:VAXXA Number of Guru Trades
XSAT:VAXXA Volume of Guru Trades
Gurus Latest Trades with XSAT:VAXXA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XSAT:VAXXA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers